Apyx Medical
APYX
59 hedge funds and large institutions have $66.9M invested in Apyx Medical in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 9 closing their positions.
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
99% more capital invested
Capital invested by funds: $33.7M → $66.9M (+$33.2M)
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
26% more funds holding
Funds holding: 47 → 59 (+12)
8.39% more ownership
Funds ownership: 41.61% → 50% (+8.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less call options, than puts
Call options by funds: $212K | Put options by funds: $275K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.85M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.22M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$859K |
| 4 |
HA
Huntleigh Advisors
St. Louis,
Missouri
|
+$824K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$703K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$321K |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$238K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$143K |
| 4 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$114K |
| 5 |
RA
Royce & Associates
New York
|
-$109K |
APYX Hedge Fund Activity: Q4 2025 in Review
59 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2025, worth a combined $66.9M — up 99% from $33.7M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new APYX positions and 9 closed out — a net gain of 12 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $3.85M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $321K sold.
- 59 institutional investors held Apyx Medical (APYX) as of Q4 2025, up from 47 in Q3 2025.
- Funds reported $66.9M of Apyx Medical stock for Q4 2025, up 99% quarter-over-quarter.
- 21 funds opened new Apyx Medical positions in Q4 2025 and 9 closed out, a net change of +12 holders.
- The largest Apyx Medical buyer in Q4 2025 was AIGH Capital Management, an estimated $3.85M added.
- The largest Apyx Medical seller in Q4 2025 was Perceptive Advisors, an estimated $321K sold.
Based on aggregated 13F filings for Q4 2025.